Novo, an investor, led a $75m Series C round in Kate Farms, a plant-based nutrition provider, with participation from Kaiser Permanente Ventures, Goldman Sachs Asset Management, Main Street Advisors. "Despite the challenging global economic environment, I'm pleased that Novo Holdings and our existing investors appreciate the significant potential of plant-based nutrition and Kate Farms' leadership in this rapidly growing market. Our brand has deeply held values, which means that finding the right investment partners is a critical choice for us. Novo Holdings' investment in Kate Farms will allow us to develop more innovative products, enter new markets and continue to serve the patients who depend on us for their nutrition, as well as thousands of healthcare providers," Brett Matthews, Kate Farms Chairman and CEO.